Recall Register

Drug recall: Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy…

Class I FDA enforcement event 90289. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Subpotent drug

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy started this drug recall on 15 Apr 2022. The firm address in the FDA record is in Berkeley, CA. FDA put the recall in Class I. FDA event 90289 has 2 product records. The first FDA enforcement report date is 15 Jun 2022. The record gives the status Terminated, with the termination date 7 Nov 2022.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

CA

Recalling firm

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy, Berkeley, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 90289: product records
Recall numberProductQuantityClassStatusReport date
D-1167-2022Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottlesClass ITerminated15 Jun 2022
D-1168-2022Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704950 mLs in 1x8 oz and 2x16 oz bottles.Class ITerminated15 Jun 2022

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2022
325
Share of these events in Class I
18%
Product records in this event
2Median of the firm: 2
Events of the firm on the register
2

Other events of the firm

Other FDA enforcement events of Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
InitiatedProduct (first record)TypeClassRecords
27 Jun 2022Nifedipine WSP 0.2% Ointment, 60 gram tubes, Rx only, Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704 Event 90539DrugClass I1

Official channels

Cite this page

Recall Register. FDA enforcement event 90289. https://recallregister.com/fda/i/90289/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: CA
What quantity of product is in FDA event 90289?
The event has 2 product records. The first record gives this quantity: 1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2022 have the same class?
18% of the 325 drug events that started in 2022 are in Class I.